New York City’s medical cannabis dispensaries are getting the brunt of the criticism this week for not having the best patient satisfaction ratings.
The New York Times reported that the city’s four dispensaries received a combined score of 0.44 on a survey of about 1,000 New Yorkers.
The average rating was 0.46, according to the Times.
A recent survey of New Yorkers found that the majority said they were satisfied with the state’s system of licensing dispensaries.
The average score was 1.6 for the four dispensaries in the survey, according the Times, and the average patient satisfaction rating was 2.5.
The Times also said the average score for the five other dispensaries was 0 out of 5, and that the average rating for a dispensary was 1 out of 10.
The report said that while the dispensaries received poor ratings, the majority of people were satisfied.
In a statement to Medical News today, The Medical Marijuana Industry Group (MMIG), a group of licensed dispensaries, called the study “shocking and completely inaccurate.”
“We have been told for over a year that dispensaries do not get high ratings, that there is no correlation between patient satisfaction and the quality of the dispensary,” said Robert Schlosser, MMIG’s president.
“This is yet another attempt to smear MMIG and the dispensaries.”
According to the MMIG, the Times article was based on an analysis of data from the Centers for Medicare and Medicaid Services (CMS) and the Drug Enforcement Administration (DEA).
The DEA is the federal agency that regulates the industry.
The Times article also claimed that the dispensaries in New York do not provide enough cannabis to meet the demand for medical cannabis.
It also claimed the dispensaries do little to protect patients from the dangers of the industry, which has been called a “high-risk industry.”
Schlosser told Medical News that the Times story was “completely wrong and completely misleading.”
“The majority of our patients do not have access to the highest quality of care, and patients do have access,” Schlossers statement continued.
“The Times has no evidence to back up its claim that we do not receive high patient satisfaction scores.
The statistics clearly show that we receive excellent patient satisfaction.”
According the Times’ data, there are 5.3 million registered patients in New England, with the largest concentration in New Hampshire.
The state also has one of the highest cannabis overdose death rates in the country.
Last year, the New York legislature passed a law that legalized recreational marijuana use, and a recent survey showed that a majority of New York voters support legalization.
The bill also includes provisions that would allow doctors to prescribe medical cannabis to people who need it.
The MMIG said the report was “further evidence that the mainstream media has no idea what they are talking about when they claim to have a monopoly on facts and unbiased reporting.”